EMERGENT BIOSOLUTIONS ACQUIRES MICROSCIENCE

Emergent BioSolutions has acquired UK-based Microscience, Ltd., a privately held vaccine company primarily involved in the research and development of innovative, proprietary vaccines and immunotherapeutics. Emergent acquired Microscience through a share exchange agreement. The terms of the acquisition were not disclosed. The acquisition will significantly bolster Emergent's commercial product development pipeline, add unique and proprietary vaccine technology and delivery platforms, and further expand the company's global operations into the important European market.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20456320&full=1)